- Q4 2023 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 27, 2024€67.5 (-5.59%)Earnings
- Q2 2023 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 26, 2023€45.94 (+9.85%)Earnings
- Q4 2022 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 28, 2023€41.7Earnings
- Laboratorios Farmaceuticos ROVI SA Capital Market Day 2022 TranscriptNov 23, 2022
- Q2 2022 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 27, 2022€57.25 (-4.42%)Earnings
- Q4 2021 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 23, 2022€72.4 (+3.43%)Earnings
- Half Year 2021 Laboratorios Farmaceuticos ROVI SA Earnings Presentation TranscriptJul 28, 2021
- Full Year 2020 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 24, 2021€45.5 (-0.44%)Earnings
- Half Year 2020 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 27, 2020€30.6Earnings
- Full Year 2019 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 26, 2020€25.2 (+1.20%)Earnings
- Half Year 2019 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 30, 2019€21.1 (+2.93%)Earnings
- Laboratorios Farmaceuticos Rovi, S.A. - Special Call TranscriptMar 19, 2019
Q2 2023 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript
Good afternoon, and welcome, everybody, to this first half results virtual meeting, which will start in a moment. This is Javier Lopez-Belmonte, ROVI's, Deputy Chairman and Chief Financial Officer.
Please let me first introduce ROVI's attendees today. Juan Lopez-Belmonte, Chairman and CEO; Marta Campos, Head of Investor Relations, Beatriz de Zavala, Investor Relations; and myself. At the end of the presentation, a question-and-answer session will commence.
If you want to ask any questions during the presentation, please do not hesitate to send them through the question button on the platform. Thank you for your presence here today. And let's now start with the presentation. I give Mr. Juan Lopez-Belmonte the floor.
Thank you, Javier, and welcome to everybody. I'm happy to present our first half results of 2023. 2023 is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)